Lista de obras - Angelo Sangiovanni - Dominio Público Uruguay

A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.

artículo científico publicado en 2009

A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.

artículo científico publicado en 2015

A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration

artículo científico publicado en 2014

A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection

artículo científico publicado en 2015

A therapeutic conundrum: Delaying ablation of small nonresectable early hepatocellular carcinoma to facilitate liver transplantation

artículo científico publicado en 2016

Advanced precancerous lesions in the liver

artículo científico publicado en 2013

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma

scientific article published on 30 November 2020

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

artículo científico publicado en 2005

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

artículo científico publicado en 2001

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

artículo científico publicado en 1989

Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.

artículo científico publicado en 1989

Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging

scientific article published on 21 October 2015

Chromogranin A levels in chronic liver disease and hepatocellular carcinoma

artículo científico publicado en 2008

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

artículo científico publicado en 2018

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

artículo científico publicado en 2014

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B

artículo científico publicado en 2018

Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients

scientific article published on 01 October 2000

Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.

artículo científico publicado en 2013

Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

artículo científico publicado en 2017

Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib.

artículo científico publicado en 2015

Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.

artículo científico publicado en 2010

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

scientific article published on 01 May 2011

Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives.

artículo científico

Etiology, natural history and treatment of hepatocellular carcinoma

artículo científico publicado en 2003

Guidelines for the management of hepatocellular carcinoma: still in need of standardization

artículo científico publicado en 2012

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

artículo científico publicado en 1998

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.

artículo científico publicado en 2015

Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.

artículo científico publicado en 2008

Hepatocellular carcinoma

artículo científico publicado en 2016

Hepatocellular carcinoma in Italian patients with cirrhosis

scientific article published on 01 September 1991

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

artículo científico publicado en 1999

How I manage my patients with hepatocellular carcinoma.

artículo científico publicado en 2011

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.

artículo científico publicado en 2007

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

artículo científico publicado en 2004

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study

scientific article published on 01 March 1998

Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy

scientific article published on 12 August 2019

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

artículo científico publicado en 2016

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

artículo científico publicado en 2018

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.

artículo científico publicado en 2001

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

artículo científico publicado en 2013

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.

artículo científico publicado en 2013

Persistence of hepatocellular carcinoma risk in hepatitis c patients with a response to ifn and cirrhosis regression

artículo científico publicado en 2018

Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

artículo científico publicado en 2017

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis

artículo científico publicado en 2013

Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation

artículo científico publicado en 1996

Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis

scientific article published on 01 March 2002

Re: Indeterminate 1-2 Cm Nodules Found on Hepatocellular Carcinoma Surveillance: Biopsy for All, Some, or None? ⬇️

artículo científico publicado el 1 de febrero de 2012

Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease.

artículo científico publicado en 2008

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment

artículo científico publicado en 2018

Specificity of the hepatitis C virus antibody ELISA in patients with hepatocellular carcinoma.

artículo científico publicado en 1990

Surveillance for hepatocellular carcinoma: a standard of care, not a clinical option

article

The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV Caucasian cirrhotics on long-term oral therapy

scientific article published on 16 April 2020

Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.

artículo científico publicado en 2015

Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.

artículo científico publicado en 2010

Transarterial embolization with microspheres in the treatment of monofocal HCC.

artículo científico publicado en 2008

Treatment of hepatocellular carcinoma: beyond international guidelines.

artículo científico

Treatment of hepatocellular carcinoma: beyond international guidelines.

artículo científico

Vitamin D deficiency and liver cancer: more than just an epidemiological association?

artículo científico publicado en 2014

Lista de obras de Angelo Sangiovanni

A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.

A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.

A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration

A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection

A therapeutic conundrum: Delaying ablation of small nonresectable early hepatocellular carcinoma to facilitate liver transplantation

Advanced precancerous lesions in the liver

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.

Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging

Chromogranin A levels in chronic liver disease and hepatocellular carcinoma

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B

Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients

Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.

Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib.

Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives.

Etiology, natural history and treatment of hepatocellular carcinoma

Guidelines for the management of hepatocellular carcinoma: still in need of standardization

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.

Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.

Hepatocellular carcinoma

Hepatocellular carcinoma in Italian patients with cirrhosis

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

How I manage my patients with hepatocellular carcinoma.

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study

Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.

Persistence of hepatocellular carcinoma risk in hepatitis c patients with a response to ifn and cirrhosis regression

Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis

Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation

Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis

Re: Indeterminate 1-2 Cm Nodules Found on Hepatocellular Carcinoma Surveillance: Biopsy for All, Some, or None? ⬇️

Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease.

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment

Specificity of the hepatitis C virus antibody ELISA in patients with hepatocellular carcinoma.

Surveillance for hepatocellular carcinoma: a standard of care, not a clinical option

The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV Caucasian cirrhotics on long-term oral therapy

Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.

Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.

Transarterial embolization with microspheres in the treatment of monofocal HCC.

Treatment of hepatocellular carcinoma: beyond international guidelines.

Treatment of hepatocellular carcinoma: beyond international guidelines.

Vitamin D deficiency and liver cancer: more than just an epidemiological association?